Tao Huang

Title: Tao Huang - Innovator in Monoclonal Antibody Development

Introduction

Tao Huang is a prominent inventor based in Palo Alto, California. He is recognized for his significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact cancer treatment and therapeutic applications.

Latest Patents

Tao Huang holds a patent for "LILRB4 antibodies and uses thereof." This patent describes an isolated monoclonal antibody or an antigen-binding fragment that specifically binds to leukocyte immunoglobulin-like receptor 4 (LILRB4). The invention outlines various embodiments where the antibody modulates the activation of LILRB4, either activating or suppressing its function. Additionally, it details a method for treating or ameliorating cancer effects in subjects by administering a therapeutically effective amount of the antibody or its fragments.

Career Highlights

Throughout his career, Tao Huang has worked with notable institutions, including the University of Texas System and Immune-Onc Therapeutics, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Tao Huang has collaborated with esteemed colleagues, including Zhiqiang An and Chengcheng Zhang. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of immunology.

Conclusion

Tao Huang's work in monoclonal antibody development exemplifies the intersection of innovation and healthcare. His contributions are paving the way for new therapeutic approaches in cancer treatment.